Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125190592 | 12519059 | 2 | F | 20160526 | 20160701 | 20160630 | 20160708 | EXP | US-AMGEN-USASL2016082010 | AMGEN | 91.00 | YR | E | F | Y | 54.88000 | KG | 20160708 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125190592 | 12519059 | 1 | PS | PROLIA | DENOSUMAB | 1 | Subcutaneous | 60 MG/ML, Q6MO | 1050641 | 125320 | SOLUTION FOR INJECTION | ||||||||
| 125190592 | 12519059 | 2 | SS | PROLIA | DENOSUMAB | 1 | Subcutaneous | UNK | 1056514 | 125320 | SOLUTION FOR INJECTION | ||||||||
| 125190592 | 12519059 | 3 | SS | PROLIA | DENOSUMAB | 1 | Subcutaneous | UNK | 1058246 | 125320 | SOLUTION FOR INJECTION | ||||||||
| 125190592 | 12519059 | 4 | SS | PROLIA | DENOSUMAB | 1 | Subcutaneous | UNK | 1063713 | 125320 | SOLUTION FOR INJECTION | ||||||||
| 125190592 | 12519059 | 5 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
| 125190592 | 12519059 | 6 | C | TOFRANIL | IMIPRAMINE HYDROCHLORIDE | 1 | Oral | 25 MG, QD | 0 | 25 | MG | QD | |||||||
| 125190592 | 12519059 | 7 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 125190592 | 12519059 | 8 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 125190592 | 12519059 | 9 | C | ZOCOR | SIMVASTATIN | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 125190592 | 12519059 | 10 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Intramuscular | 1 ML, QMO | 0 | 1 | ML | /month | |||||||
| 125190592 | 12519059 | 11 | C | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, BID | 0 | 500 | MG | BID | |||||||
| 125190592 | 12519059 | 12 | C | MICRONASE | GLYBURIDE | 1 | Oral | 2.5 MG, BID | 0 | 2.5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125190592 | 12519059 | 1 | Osteoporosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125190592 | 12519059 | OT |
| 125190592 | 12519059 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125190592 | 12519059 | Arthralgia | |
| 125190592 | 12519059 | Constipation | |
| 125190592 | 12519059 | Contusion | |
| 125190592 | 12519059 | Fall | |
| 125190592 | 12519059 | Humerus fracture | |
| 125190592 | 12519059 | Inappropriate schedule of drug administration | |
| 125190592 | 12519059 | Upper limb fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125190592 | 12519059 | 1 | 20141120 | 0 | ||
| 125190592 | 12519059 | 2 | 20150521 | 0 | ||
| 125190592 | 12519059 | 3 | 20151123 | 0 | ||
| 125190592 | 12519059 | 4 | 20160622 | 0 |